Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Advances in Experimental Medicine and Biology
|
January 1, 1989
3'-azido-3'-deoxythymidine and acyclovir: antiviral nucleoside analogues with unusual cell membrane permeation properties
T P Zimmerman, K L Prus, W B Mahony, et al.
The Journal of Biological Chemistry
|
October 5, 1992
Enantiomeric selectivity of carbovir transport
W B Mahony, B A Domin, S M Daluge, et al.
Molecular Pharmacology
|
May 1, 1992
Membrane permeation characteristics of 5'-modified thymidine analogs
B A Domin, W B Mahony, G W Koszalka, et al.
Journal of Clinical Pharmacology
|
March 28, 2001
Abacavir/lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with each component administered concurrently and the effect of food on absorption
G J Yuen, Y Lou, N F Thompson, et al.
Anti-Cancer Drug Design
|
January 5, 2002
A prodrug approach to the design of cRaf1 kinase inhibitors with improved cellular activity
E Wood, R M Crosby, S Dickerson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Advances in Experimental Medicine and Biology
|
January 1, 1989
3'-azido-3'-deoxythymidine and acyclovir: antiviral nucleoside analogues with unusual cell membrane permeation properties
T P Zimmerman, K L Prus, W B Mahony, et al.
The Journal of Biological Chemistry
|
October 5, 1992
Enantiomeric selectivity of carbovir transport
W B Mahony, B A Domin, S M Daluge, et al.
Molecular Pharmacology
|
May 1, 1992
Membrane permeation characteristics of 5'-modified thymidine analogs
B A Domin, W B Mahony, G W Koszalka, et al.
Journal of Clinical Pharmacology
|
March 28, 2001
Abacavir/lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with each component administered concurrently and the effect of food on absorption
G J Yuen, Y Lou, N F Thompson, et al.
Anti-Cancer Drug Design
|
January 5, 2002
A prodrug approach to the design of cRaf1 kinase inhibitors with improved cellular activity
E Wood, R M Crosby, S Dickerson, et al.
Page
of 2